IRLAB Therapeutics AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	50.79	81.86	66.92	111.31	252.78	401.9
Cash & Short-Term Investments	50.79	81.86	66.92	111.31	252.78	401.9
Cash Growth	-42.68%	22.33%	-39.88%	-55.96%	-37.10%	45.08%
Accounts Receivable	32.95	4.01	-	-	3.32	4.47
Other Receivables	-	-	10.08	9.17	8.9	6.27
Receivables	32.95	4.01	10.08	9.17	12.22	10.74
Prepaid Expenses	-	-	2.2	2.8	3.34	2.28
Other Current Assets	-	-0	0.37	0.31	0.35	6.52
Total Current Assets	83.74	85.87	79.56	123.59	268.68	421.44
Property, Plant & Equipment	4.43	5.47	9.79	6.67	8.01	8.35
Other Intangible Assets	46.86	46.86	46.86	46.86	46.86	42.4
Long-Term Deferred Charges	-	-	-	-	-	0.26
Other Long-Term Assets	0	-	-0	-	-0	-0
Total Assets	135.03	138.21	136.21	177.12	323.56	472.45
Accounts Payable	-	-	9.94	10.52	10.03	12.3
Accrued Expenses	-	-	11.68	14.91	13.44	5.84
Short-Term Debt	24.41	26.42	53.47	-	-	-
Current Portion of Leases	2.67	3.54	3.42	2.94	3.6	3.03
Current Unearned Revenue	-	-	-	-	-	42.58
Other Current Liabilities	68.11	77.54	21.54	8.35	5.28	5.65
Total Current Liabilities	95.19	107.49	100.04	36.73	32.34	69.4
Long-Term Debt	-	-	-	24.51	-	-
Long-Term Leases	-	-	3.54	0.12	0.38	3.57
Total Liabilities	95.19	107.49	103.58	61.36	32.72	72.97
Common Stock	1.7	1.7	1.04	1.04	1.04	1.04
Additional Paid-In Capital	800.41	800.41	690.21	690.21	690.21	685.45
Retained Earnings	-762.27	-771.39	-658.61	-575.48	-400.41	-287
Comprehensive Income & Other	-	-	0	-	-	-
Shareholders' Equity	39.84	30.72	32.64	115.76	290.83	399.48
Total Liabilities & Equity	135.03	138.21	136.21	177.12	323.56	472.45
Total Debt	27.08	29.95	60.42	27.57	3.98	6.6
Net Cash (Debt)	23.7	51.91	6.5	83.74	248.8	395.3
Net Cash Growth	7.04%	699.06%	-92.24%	-66.34%	-37.06%	44.23%
Net Cash Per Share	0.32	0.77	0.13	1.61	4.80	7.64
Filing Date Shares Outstanding	81.88	84.94	51.87	51.87	51.87	51.75
Total Common Shares Outstanding	81.88	84.94	51.87	51.87	51.87	51.75
Working Capital	-11.45	-21.62	-20.48	86.86	236.34	352.04
Book Value Per Share	0.49	0.36	0.63	2.23	5.61	7.72
Tangible Book Value	-7.02	-16.14	-14.23	68.9	243.97	357.08
Tangible Book Value Per Share	-0.09	-0.19	-0.27	1.33	4.70	6.90
Machinery	-	-	7.02	6.82	6.53	3.65
Leasehold Improvements	-	-	0.12	0.12	0.12	0.12

Source: S&P Global Market Intelligence. Standard template. Financial Sources.